These antibodies detected at month-1 could be the result of passive immunization (47) through the placenta during the pregnancy (IgG) or via mother's milk (most of them are IgA), to protect the offspring from potential threats like bacterial infections during the first stage of life. This evidence concerns the gene CD79A and bacterial infectious disease.